Publications by authors named "N Alshatti"

Claim this Profile
P
Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial).
N Alshatti, F Lemonnier, E Bachy, J Lopez, F Llamas

Immunooncol Technol· March 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatal COVID-19 is Associated with Reduced HLA-DR, CD123 or CD11c Expression on Circulating Dendritic Cells.
Amal Hasan, Ebaa Al-Ozairi, Nosiba Y M Hassan, Shamsha Ali, Rasheed Ahmad

J Inflamm Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergizing liver systemic treatments with interventional oncology: friend or foe?
Raphaël Jost, Nael Al-Shatti, Mario Ghosn, Baptiste Bonnet, Stephane Champiat

Br J Radiol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro modeling of glioblastoma initiation using PDGF-AA and p53-null neural progenitors.
Alexandra K Bohm, Jessica DePetro, Carmen E Binding, Amanda Gerber, Nicholas Chahley, Nourah Alshatti

Neuro Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heat inactivation can differentiate between IgG and IgM antibodies in the pretransplant cross match.
I A Al-Muzairai, M Mansour, L Almajed, N Alkanderi, N Alshatti

Transplant Proc· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis